UCrest Berhad, an investment holding company, (0005) Fair Value & Analysis
Healthcare · MY · Market cap 48.3M MYR
Fair value as of: Jul 17, 2026
From 24 valuation models · updated 21 days ago
Share price −7.7% over the past month.
Below-average quality, screening 68% undervalued on our models.
What matters now
- The price is below even our cautious bear case (0.0748 MYR). The market is more pessimistic than our downside scenario.
- Solid quality (45/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.
How to read this chart
60‑month range 0.0550 MYR – 0.5950 MYR · fair‑value band 0.0748 MYR – 0.1203 MYR · the 0.0600 MYR price screens below the 0.1008 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 17, 2026.
Analysis
UCrest Berhad, an investment holding company, (0005) currently trades at 0.0600 MYR, while our model-based Fair Value estimate is 0.1008 MYR, implying the stock looks roughly 68.0% undervalued today. We read business quality at 45/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, UCrest Berhad, an investment holding company, generated revenue of 14.0M MYR at a net margin of 15.1%. Revenue declined 44.8% year over year. It earns a return on equity of 4.9%. Fundamentals as of Jul 17, 2026
Our scenario range runs from 0.0748 MYR (bear case) to 0.1203 MYR (bull case); at 0.0600 MYR, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 40% below its 52-week high and 9% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -53% fair-value upside, at 68%, 0005 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Growth Earnings (0.1700 MYR) versus Asset-Based (0.0400 MYR). Highest evidence: Growth DCF (72).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 56 · Market factors (momentum, volatility) 31
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
UCrest Berhad, an investment holding company, engages in the design, development, and marketing of information technology related products and services in Malaysia and Singapore.
Full company description
UCrest Berhad, an investment holding company, engages in the design, development, and marketing of information technology related products and services in Malaysia and Singapore. The company offers iMedic cloud hospital that is used by doctors and patients for the diagnosis, management, and treatment of chronic diseases, such as cardiovascular diseases (CVD), cancer, diabetes, hypertension, sleep apnea, stroke rehabilitation, and other diseases in the United States, China, Singapore, Malaysia, Taiwan, Indonesia, Vietnam, and the Middle East. It also provides mobile healthcare services. The company was formerly known as Palette Multimedia Berhad and changed its name to UCrest Berhad in November 2017. UCrest Berhad was incorporated in 1997 and is based in Petaling Jaya, Malaysia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
UCrest Berhad, an investment holding company, reported revenue of 18.1M MYR in FY2024 versus 25.5M MYR in FY2020, a compound −8.2%/yr. Reported net income was 4.7M MYR in FY2024, compounding −20.0%/yr from FY2020.
Watch 0005: get an alert when its fair value changes →
Peer Group
Health Information Services · 127 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Health Information Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $190.12 | $95.12 | -50% |
| Pro Medicus Limited PME | A$194.84 | A$23.74 | -88% |
| BrightSpring Health Services, Inc BTSG | $68.16 | $21.31 | -69% |
| HealthEquity, Inc HQY | $97.67 | $56.63 | -42% |
| Hinge Health, Inc HNGE | $88.80 | $24.03 | -73% |
| 10x Genomics, Inc TXG | $45.75 | $17.18 | -62% |
| Waystar Holding WAY | $22.69 | $12.86 | -43% |
| Doximity, Inc DOCS | $22.21 | $17.18 | -23% |
| Privia Health Group PRVA | $28.10 | $5.30 | -81% |
| Inventurus Knowledge Solutions Limited IKS | ₹1,846 | ₹860.28 | -53% |
Compare UCrest Berhad, an investment holding company, with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is UCrest Berhad, an investment holding company, (0005) overvalued or undervalued?
What is the fair value of 0005?
What is the quality score of 0005?
What is the revenue of UCrest Berhad, an investment holding company, (0005)?
What is the net profit margin of 0005?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track UCrest Berhad, an investment holding company, and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.